Comparative risk of acute kidney injury in oncology patients receiving vancomycin monotherapy versus vancomycin with piperacillin-tazobactam: a retrospective cohort study
Authors
Ali Sabateen
Hasan Arafat (ORCID: https://orcid.org/0000-0002-6484-5606)
Dana Sadaqa (ORCID: https://orcid.org/0000-0003-0317-4818)
Ibrahim Bsharat (ORCID: https://orcid.org/0009-0004-3522-9654)
Mohammad Yaish (ORCID: https://orcid.org/0009-0006-4889-9424)
Comparative risk of acute kidney injury in oncology patients receiving vancomycin monotherapy versus vancomycin with piperacillin-tazobactam: a retrospective cohort study
Ali Sabateen, Hasan Arafat, Dana Sadaqa, Ibrahim Bsharat et al.
Journal
BMC Pharmacology and Toxicology
Topics
Acute Kidney Injury Research
article
Comparative risk of acute kidney injury in oncology patients receiving vancomycin monotherapy versus vancomycin with piperacillin-tazobactam: a retrospective cohort study
Ali Sabateen, Hasan Arafat, Dana Sadaqa, Ibrahim Bsharat, Mohammad Yaish, Hamza Alsaid, Hammam Rjoup, Ayman Shoibat
article en
Abstract
No abstract available for this paper.
Publication Tag
BMC Pharmacology and Toxicology
Institutions
Hadassah Medical Center (IL), Augusta Victoria Hospital (IL)